Thomas Mariani
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Gene Expression Profiling | 18 | 2002 | 138 |
Why?
| Lung | 26 | 1995 | 232 |
Why?
| Oligonucleotide Array Sequence Analysis | 16 | 2002 | 135 |
Why?
| Pulmonary Disease, Chronic Obstructive | 7 | 2005 | 25 |
Why?
| PPAR gamma | 3 | 2006 | 38 |
Why?
| Pulmonary Alveoli | 6 | 1995 | 80 |
Why?
| Respiratory Mucosa | 4 | 2006 | 39 |
Why?
| Biological Markers | 3 | 2008 | 262 |
Why?
| Epithelial Cells | 7 | 1998 | 135 |
Why?
| Elastin | 6 | 1995 | 22 |
Why?
| Gene Expression Regulation, Developmental | 4 | 2002 | 119 |
Why?
| Tropoelastin | 6 | 1995 | 4 |
Why?
| Genetic Predisposition to Disease | 5 | 1992 | 131 |
Why?
| Amyloid beta-Protein Precursor | 3 | 2005 | 15 |
Why?
| Mice | 21 | 1973 | 623 |
Why?
| Extracellular Matrix | 3 | 1998 | 79 |
Why?
| SOXD Transcription Factors | 1 | 2011 | 4 |
Why?
| Animals | 32 | 1973 | 1031 |
Why?
| Silicosis | 4 | 1995 | 6 |
Why?
| Asthma | 7 | 2006 | 97 |
Why?
| Gene Expression | 5 | 1995 | 291 |
Why?
| Receptors, Cell Surface | 4 | 2005 | 115 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 7 |
Why?
| Microarray Analysis | 2 | 2006 | 24 |
Why?
| Fetal Development | 1 | 2009 | 13 |
Why?
| Mesoderm | 1 | 2010 | 35 |
Why?
| Fibroblasts | 6 | 1982 | 179 |
Why?
| DNA Probes | 2 | 2004 | 61 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2002 | 104 |
Why?
| Macrophages | 2 | 1998 | 148 |
Why?
| Reproducibility of Results | 6 | 2002 | 391 |
Why?
| Granuloma | 2 | 1995 | 38 |
Why?
| Macrophages, Peritoneal | 1 | 2005 | 12 |
Why?
| Lovastatin | 1 | 2005 | 13 |
Why?
| Metalloendopeptidases | 1 | 2005 | 25 |
Why?
| RNA, Messenger | 8 | 1992 | 394 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 34 |
Why?
| DNA | 4 | 1992 | 262 |
Why?
| Stem Cells | 2 | 2004 | 107 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 1998 | 210 |
Why?
| Humans | 34 | 1982 | 1856 |
Why?
| Collagenases | 2 | 1998 | 21 |
Why?
| Muscle, Smooth | 2 | 1995 | 69 |
Why?
| Procollagen | 3 | 1992 | 7 |
Why?
| Actins | 2 | 1995 | 112 |
Why?
| Polymorphism, Single Nucleotide | 5 | 2005 | 39 |
Why?
| Principal Component Analysis | 2 | 2008 | 18 |
Why?
| Protein-Lysine 6-Oxidase | 3 | 1992 | 2 |
Why?
| Collagen | 4 | 1992 | 118 |
Why?
| Bronchi | 3 | 2006 | 45 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 1998 | 2 |
Why?
| Gene Expression Regulation | 4 | 1995 | 277 |
Why?
| Mice, Inbred C57BL | 6 | 1973 | 318 |
Why?
| Pulmonary Fibrosis | 2 | 1995 | 48 |
Why?
| Mice, Knockout | 4 | 2006 | 265 |
Why?
| Cell Line | 7 | 1982 | 375 |
Why?
| Lung Diseases | 2 | 1995 | 112 |
Why?
| Rats, Sprague-Dawley | 5 | 1995 | 257 |
Why?
| Phenotype | 4 | 1992 | 303 |
Why?
| Rats | 7 | 1992 | 530 |
Why?
| Cluster Analysis | 3 | 2002 | 66 |
Why?
| Transforming Growth Factor beta | 2 | 1995 | 99 |
Why?
| Cell Line, Tumor | 4 | 2004 | 208 |
Why?
| Pneumonia | 2 | 2006 | 85 |
Why?
| Gestational Age | 3 | 2009 | 114 |
Why?
| Disease Models, Animal | 4 | 1996 | 349 |
Why?
| Culture Media, Conditioned | 3 | 1998 | 45 |
Why?
| Databases, Genetic | 2 | 2002 | 20 |
Why?
| Pulmonary Medicine | 1 | 2002 | 1 |
Why?
| Protease Nexins | 3 | 2005 | 2 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 1992 | 8 |
Why?
| Respiratory Tract Diseases | 1 | 2002 | 34 |
Why?
| Cardiology | 1 | 2002 | 25 |
Why?
| Extracellular Matrix Proteins | 1 | 1992 | 45 |
Why?
| Case-Control Studies | 2 | 2009 | 283 |
Why?
| Lung Neoplasms | 2 | 2004 | 159 |
Why?
| Genes, ras | 2 | 1992 | 24 |
Why?
| Pulmonary Surfactant-Associated Proteins | 1 | 2010 | 11 |
Why?
| Lung Volume Measurements | 1 | 2010 | 22 |
Why?
| Morphogenesis | 2 | 1997 | 47 |
Why?
| Aged | 6 | 1992 | 988 |
Why?
| Surface Tension | 1 | 2010 | 15 |
Why?
| Mechanotransduction, Cellular | 1 | 2010 | 13 |
Why?
| Elasticity | 1 | 2010 | 30 |
Why?
| Bronchoalveolar Lavage Fluid | 4 | 1999 | 68 |
Why?
| Iron Regulatory Protein 2 | 1 | 2009 | 2 |
Why?
| Middle Aged | 6 | 1992 | 1161 |
Why?
| Biomechanics | 1 | 2010 | 79 |
Why?
| Smoking | 3 | 2005 | 153 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 243 |
Why?
| Linear Models | 2 | 2005 | 151 |
Why?
| Matrix Metalloproteinase 13 | 2 | 1998 | 11 |
Why?
| Wnt Proteins | 1 | 2009 | 24 |
Why?
| Lipoxins | 1 | 2008 | 2 |
Why?
| Receptors, Lipoxin | 1 | 2008 | 2 |
Why?
| Receptors, Formyl Peptide | 1 | 2008 | 4 |
Why?
| Female | 10 | 1992 | 1643 |
Why?
| Computational Biology | 1 | 2009 | 39 |
Why?
| Cytoskeletal Proteins | 1 | 2009 | 55 |
Why?
| Cardiovascular Diseases | 1 | 2002 | 127 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 54 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 224 |
Why?
| Receptors, IgE | 1 | 2007 | 8 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 73 |
Why?
| RNA, Neoplasm | 2 | 2004 | 41 |
Why?
| Cathepsins | 1 | 2007 | 12 |
Why?
| Immunity, Maternally-Acquired | 1 | 2007 | 12 |
Why?
| Sequence Analysis | 2 | 1995 | 23 |
Why?
| Transcription, Genetic | 2 | 1998 | 253 |
Why?
| Vehicle Emissions | 1 | 2007 | 14 |
Why?
| Pulmonary Surfactants | 1 | 2009 | 35 |
Why?
| Blotting, Northern | 2 | 1992 | 151 |
Why?
| Analysis of Variance | 1 | 2010 | 339 |
Why?
| Breast | 2 | 2004 | 40 |
Why?
| STAT3 Transcription Factor | 1 | 2007 | 19 |
Why?
| Allergens | 1 | 2007 | 28 |
Why?
| Particulate Matter | 1 | 2007 | 22 |
Why?
| Male | 9 | 1992 | 1553 |
Why?
| Sequence Analysis, DNA | 2 | 2004 | 110 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2007 | 24 |
Why?
| beta Catenin | 1 | 2008 | 34 |
Why?
| Serpins | 1 | 2006 | 14 |
Why?
| Maternal-Fetal Exchange | 1 | 2007 | 49 |
Why?
| Titanium | 1 | 2007 | 36 |
Why?
| Plasminogen | 1 | 2006 | 8 |
Why?
| Age Factors | 1 | 2010 | 480 |
Why?
| Maternal Exposure | 1 | 2007 | 24 |
Why?
| Enzyme Activation | 2 | 2005 | 177 |
Why?
| Fibrinolysin | 1 | 2006 | 9 |
Why?
| Crosses, Genetic | 1 | 2006 | 47 |
Why?
| Hyperoxia | 1 | 2007 | 26 |
Why?
| Pregnancy | 2 | 2007 | 455 |
Why?
| Oligonucleotide Probes | 1 | 2005 | 40 |
Why?
| Matrix Metalloproteinase 12 | 1 | 2005 | 2 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2005 | 4 |
Why?
| Mice, Inbred Strains | 1 | 2006 | 118 |
Why?
| Genetic Linkage | 1 | 2005 | 57 |
Why?
| Oxidative Stress | 1 | 2009 | 119 |
Why?
| Air Pollutants | 1 | 2007 | 42 |
Why?
| Molecular Diagnostic Techniques | 1 | 2004 | 7 |
Why?
| RNA | 1 | 2008 | 126 |
Why?
| Kinetics | 2 | 1998 | 349 |
Why?
| Up-Regulation | 1 | 2006 | 183 |
Why?
| DNA, Neoplasm | 1 | 2004 | 75 |
Why?
| Lung Injury | 2 | 1998 | 36 |
Why?
| Aged, 80 and over | 2 | 2000 | 599 |
Why?
| Sister Chromatid Exchange | 1 | 1982 | 4 |
Why?
| Crossing Over, Genetic | 1 | 1982 | 8 |
Why?
| Expressed Sequence Tags | 1 | 2002 | 13 |
Why?
| Multigene Family | 1 | 2002 | 52 |
Why?
| Aneurysm | 2 | 1992 | 20 |
Why?
| Superoxide Dismutase | 1 | 2002 | 46 |
Why?
| Genes, Regulator | 1 | 2002 | 20 |
Why?
| Algorithms | 1 | 2005 | 226 |
Why?
| Cell Communication | 1 | 1982 | 72 |
Why?
| Breast Neoplasms | 2 | 2004 | 185 |
Why?
| Isotretinoin | 1 | 2000 | 9 |
Why?
| Time Factors | 2 | 1996 | 896 |
Why?
| Carcinoma, Renal Cell | 1 | 2000 | 48 |
Why?
| Interferon-alpha | 1 | 2000 | 43 |
Why?
| Adult | 4 | 1995 | 1317 |
Why?
| Kidney Neoplasms | 1 | 2000 | 75 |
Why?
| Ultraviolet Rays | 2 | 1982 | 76 |
Why?
| Enzyme Induction | 1 | 1998 | 64 |
Why?
| Arachidonic Acid | 1 | 1998 | 29 |
Why?
| Transcription Factor AP-1 | 1 | 1998 | 42 |
Why?
| Animals, Newborn | 2 | 2007 | 175 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1998 | 83 |
Why?
| Cells, Cultured | 3 | 1982 | 447 |
Why?
| Embryonic and Fetal Development | 1 | 1997 | 52 |
Why?
| Serpin E2 | 2 | 2005 | 3 |
Why?
| Cohort Studies | 2 | 2009 | 332 |
Why?
| Macrophages, Alveolar | 2 | 2006 | 44 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 121 |
Why?
| Solubility | 1 | 1995 | 75 |
Why?
| Molecular Sequence Data | 4 | 1992 | 404 |
Why?
| Organ Size | 1 | 1996 | 118 |
Why?
| Skin | 2 | 1992 | 177 |
Why?
| Tissue Distribution | 1 | 1995 | 124 |
Why?
| Lymphocytes | 2 | 1973 | 142 |
Why?
| Cell Count | 2 | 1982 | 163 |
Why?
| Pulmonary Emphysema | 1 | 1995 | 24 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 32 |
Why?
| Organ Specificity | 2 | 1995 | 104 |
Why?
| Base Sequence | 4 | 1993 | 371 |
Why?
| Histocompatibility Antigens | 1 | 1973 | 17 |
Why?
| Skin Transplantation | 1 | 1973 | 39 |
Why?
| Sequence Homology | 1 | 1992 | 12 |
Why?
| Models, Biological | 1 | 1998 | 410 |
Why?
| Hybrid Cells | 1 | 1992 | 16 |
Why?
| Immunohistochemistry | 2 | 2005 | 355 |
Why?
| Genes | 1 | 1992 | 82 |
Why?
| Amino Acid Sequence | 2 | 1992 | 319 |
Why?
| Chromosome Mapping | 1 | 1992 | 107 |
Why?
| Species Specificity | 1 | 1992 | 186 |
Why?
| Colorectal Neoplasms | 1 | 1992 | 55 |
Why?
| Odds Ratio | 1 | 2011 | 157 |
Why?
| Genetic Association Studies | 1 | 2009 | 4 |
Why?
| Vital Capacity | 1 | 2009 | 25 |
Why?
| Mice, Inbred BALB C | 2 | 1973 | 176 |
Why?
| Forced Expiratory Volume | 1 | 2009 | 29 |
Why?
| Child | 2 | 2007 | 749 |
Why?
| Family Health | 1 | 2009 | 69 |
Why?
| Integrases | 1 | 2009 | 36 |
Why?
| Genomics | 1 | 2009 | 36 |
Why?
| NF-E2-Related Factor 2 | 1 | 2009 | 15 |
Why?
| Epithelium | 1 | 2009 | 101 |
Why?
| Models, Genetic | 1 | 2009 | 90 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2008 | 5 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 75 |
Why?
| Cilia | 1 | 2008 | 10 |
Why?
| Cell Separation | 1 | 2009 | 110 |
Why?
| Gene Deletion | 1 | 2009 | 121 |
Why?
| RNA, Small Interfering | 1 | 2009 | 116 |
Why?
| S Phase | 1 | 2008 | 29 |
Why?
| Budesonide | 1 | 2007 | 6 |
Why?
| Desmosine | 1 | 2007 | 1 |
Why?
| Hydroxyproline | 1 | 2007 | 16 |
Why?
| Immunoglobulin E | 1 | 2007 | 28 |
Why?
| Mites | 1 | 2007 | 7 |
Why?
| Administration, Inhalation | 1 | 2007 | 60 |
Why?
| Antioxidants | 1 | 2009 | 84 |
Why?
| Adrenal Cortex Hormones | 1 | 2007 | 76 |
Why?
| Dust | 1 | 2007 | 22 |
Why?
| Thermodynamics | 1 | 2008 | 45 |
Why?
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 8 |
Why?
| Bronchoconstriction | 1 | 2006 | 7 |
Why?
| Risk Assessment | 1 | 2011 | 324 |
Why?
| Wound Healing | 1 | 2008 | 106 |
Why?
| Th2 Cells | 1 | 2007 | 36 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2006 | 28 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 26 |
Why?
| Tissue Plasminogen Activator | 1 | 2006 | 31 |
Why?
| Lod Score | 1 | 2005 | 17 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2006 | 38 |
Why?
| Haplotypes | 1 | 2005 | 28 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2006 | 42 |
Why?
| Mice, Mutant Strains | 1 | 2006 | 77 |
Why?
| Flow Cytometry | 1 | 2008 | 216 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 279 |
Why?
| Stress, Mechanical | 1 | 2006 | 93 |
Why?
| Polymorphism, Genetic | 1 | 2006 | 94 |
Why?
| Chronic Disease | 1 | 2007 | 267 |
Why?
| Reference Values | 1 | 2006 | 278 |
Why?
| Cell Movement | 1 | 2007 | 163 |
Why?
| Mice, Transgenic | 1 | 2007 | 209 |
Why?
| DNA Primers | 1 | 2006 | 208 |
Why?
| Cell Proliferation | 1 | 2008 | 227 |
Why?
| Risk Factors | 1 | 2011 | 555 |
Why?
| Proteins | 1 | 2007 | 192 |
Why?
| Severity of Illness Index | 1 | 2007 | 358 |
Why?
| Exons | 2 | 1993 | 91 |
Why?
| DNA, Complementary | 1 | 2004 | 139 |
Why?
| Cytokines | 1 | 2007 | 207 |
Why?
| Inflammation | 1 | 2007 | 208 |
Why?
| Ethyl Methanesulfonate | 1 | 1982 | 6 |
Why?
| Xeroderma Pigmentosum | 1 | 1982 | 3 |
Why?
| Aortic Aneurysm | 2 | 1992 | 16 |
Why?
| Aorta, Abdominal | 2 | 1992 | 15 |
Why?
| Infant, Newborn | 1 | 2007 | 389 |
Why?
| Evolution, Molecular | 1 | 2002 | 45 |
Why?
| Cell Differentiation | 1 | 2008 | 262 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 126 |
Why?
| Cricetinae | 1 | 1982 | 130 |
Why?
| Injections, Subcutaneous | 1 | 2000 | 63 |
Why?
| Adolescent | 1 | 2009 | 891 |
Why?
| Disease-Free Survival | 1 | 2000 | 102 |
Why?
| Statistics, Nonparametric | 1 | 2000 | 141 |
Why?
| Administration, Oral | 1 | 2000 | 170 |
Why?
| Signal Transduction | 1 | 2008 | 313 |
Why?
| Multivariate Analysis | 1 | 2000 | 225 |
Why?
| Models, Statistical | 1 | 2000 | 114 |
Why?
| Survival Analysis | 1 | 2000 | 205 |
Why?
| Recombinant Proteins | 1 | 2000 | 290 |
Why?
| Quality of Life | 1 | 2000 | 188 |
Why?
| Questionnaires | 1 | 2000 | 360 |
Why?
| Adenosine Monophosphate | 1 | 1995 | 14 |
Why?
| DNA Repair | 1 | 1995 | 47 |
Why?
| Fetus | 1 | 1995 | 105 |
Why?
| DNA, Recombinant | 1 | 1993 | 34 |
Why?
| Consensus Sequence | 1 | 1993 | 39 |
Why?
| Protein Biosynthesis | 1 | 1995 | 113 |
Why?
| Peyer's Patches | 1 | 1973 | 7 |
Why?
| Mice, Inbred A | 1 | 1973 | 15 |
Why?
| Mice, Inbred DBA | 1 | 1973 | 38 |
Why?
| Alleles | 1 | 1993 | 108 |
Why?
| Immunity, Cellular | 1 | 1973 | 85 |
Why?
| Protein Denaturation | 1 | 1992 | 18 |
Why?
| Treatment Outcome | 1 | 2000 | 661 |
Why?
| Graft Rejection | 1 | 1973 | 59 |
Why?
| Transplantation, Homologous | 1 | 1973 | 94 |
Why?
| Lymph Nodes | 1 | 1973 | 106 |
Why?
| Prevalence | 1 | 1992 | 281 |
Why?
| Recurrence | 1 | 1992 | 261 |
Why?
| Mutation | 1 | 1992 | 340 |
Why?
|
|
Mariani's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
